Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA561555
Max Phase: Preclinical
Molecular Formula: C15H19NO6
Molecular Weight: 309.32
Molecule Type: Small molecule
Associated Items:
ID: ALA561555
Max Phase: Preclinical
Molecular Formula: C15H19NO6
Molecular Weight: 309.32
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COC(=O)CC(N)(CC(=O)OC)C(=O)OCc1ccccc1
Standard InChI: InChI=1S/C15H19NO6/c1-20-12(17)8-15(16,9-13(18)21-2)14(19)22-10-11-6-4-3-5-7-11/h3-7H,8-10,16H2,1-2H3
Standard InChI Key: DJQPFSNRSCABSF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 309.32 | Molecular Weight (Monoisotopic): 309.1212 | AlogP: 0.55 | #Rotatable Bonds: 7 |
Polar Surface Area: 104.92 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 5.86 | CX LogP: 0.73 | CX LogD: 0.72 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.58 | Np Likeness Score: 0.15 |
1. Beck J, Vercheval L, Bebrone C, Herteg-Fernea A, Lassaux P, Marchand-Brynaert J.. (2009) Discovery of novel lipophilic inhibitors of OXA-10 enzyme (class D beta-lactamase) by screening amino analogs and homologs of citrate and isocitrate., 19 (13): [PMID:19467869] [10.1016/j.bmcl.2009.04.149] |
Source(1):